{"name":"Seegpharm S.A.","slug":"seegpharm-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dapsone 5.0% Gel (Allergan)","genericName":"Dapsone 5.0% Gel (Allergan)","slug":"dapsone-5-0-gel-allergan","indication":"Acne vulgaris (topical gel formulation)","status":"phase_3"},{"name":"Dapsone 5.0% Gel (SEEGPharm)","genericName":"Dapsone 5.0% Gel (SEEGPharm)","slug":"dapsone-5-0-gel-seegpharm","indication":"Acne vulgaris (topical gel formulation)","status":"phase_3"}]}],"pipeline":[{"name":"Dapsone 5.0% Gel (Allergan)","genericName":"Dapsone 5.0% Gel (Allergan)","slug":"dapsone-5-0-gel-allergan","phase":"phase_3","mechanism":"Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties through suppression of neutrophil function and reactive oxygen species production.","indications":["Acne vulgaris (topical gel formulation)"],"catalyst":""},{"name":"Dapsone 5.0% Gel (SEEGPharm)","genericName":"Dapsone 5.0% Gel (SEEGPharm)","slug":"dapsone-5-0-gel-seegpharm","phase":"phase_3","mechanism":"Dapsone is a sulfone antibiotic that inhibits bacterial dihydropteroate synthase and has anti-inflammatory properties through suppression of neutrophil function and reactive oxygen species production.","indications":["Acne vulgaris (topical gel formulation)","Rosacea (potential indication based on anti-inflammatory properties)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNM05SLVM4SGNXenNvTW1kcVVsaGVZMGlnRVVqOXI1R0hZVWhGSXNuTC10Z0lJcFZPc3NZVkR0d1BhV3ZNQ1NwT0NLTm4wdk5FUUZIdW1tRnNRbXI1VVdVMEdMc0E1Y212U0d0S0NyakQzQzlRZkFSOWlzR2lyNmJCVVdIcWx3bHIyZDFxQlVFdU94b2JDemhQX3k5V01qRW1la2pmOV9WakpJQ09i?oc=5","date":"2023-07-13","type":"pipeline","source":"BioSpace","summary":"Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5% - BioSpace","headline":"Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxNZjRsSElBblpITTY5M1lkQWZGemZsRk8wVkxCMkZwUlZ1X21EQ081OC1aNnN0ekJmRzh1anQ2V2xnMVNvMnB5X190R2RNUmhyN3RJdm5fNmswbEx1SjN5dlFvM3lOX25wS2pCa09sSFpTZkh0eVFHNWloYXBXMHB4VmFWeGs1a2pIT2UwLU5tdjFCdFluNXdhMFBxdE1hSjZQMi1DOEJzU0lFVU1USFdPUVo1X0NhTWhRaDc1SDRIMWVQUQ?oc=5","date":"2023-07-13","type":"pipeline","source":"Business Wire","summary":"Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5% - Business Wire","headline":"Cosette Pharmaceuticals Launches Dapsone 5% Gel, AB-Rated to Aczone® 5%","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}